Table 3

Genotype and allele frequencies of rs7234029 in patients and controls stratified by the main clinical features

Clinical featuresGenotype alleleBDControlsP valuePvalueOR95% CI
N%N%
Genital ulcerA7220.70630930.710.82NS0.9830.846 to 1.141
AA2300.4511020.5060.023NS0.7990.659 to 0.970
AG2620.5138890.4081.72×10−5 7.40×10−4 1.5261.257 to 1.851
GG190.0371870.0861.97×10−4 8.47×10−3 0.4110.254 to 0.666
Skin lesionsA9510.69130930.710.179NS0.9140.801 to 1.042
AA2940.42711020.5063.21×10−4 1.38×10−2 0.7290.613 to 0.866
AG3630.5288890.4083.66×10−8 1.57×10−6 1.6191.363 to 1.924
GG310.0451870.0864.33×10−4 1.86×10−2 0.5020.340 to 0.742
HypopyonA3110.69730930.710.573NS0.9410.761 to 1.163
AA980.43911020.5060.059NS0.7660.580 to 1.010
AG1150.5168890.4080.002NS1.5441.171 to 2.035
GG100.0451870.0860.034NS0.50.261 to 0.959
ArthritisA2160.70130930.710.744NS0.9590.745 to 1.234
AA700.45511020.5060.217NS0.8140.586 to 1.130
AG760.4948890.4080.038NS1.4131.018 to 1.960
GG80.0521870.0860.142NS0.5830.282 to 1.207
Positive pathergy testA2030.70530930.710.851NS0.9750.751 to 1.267
AA610.42411020.5060.056NS0.7180.510 to 1.009
AG810.5628890.4082.76×10−4 1.19×10−2 1.8641.327 to 2.620
GG20.0141870.0860.002NS0.150.037 to 0.610
  • NS, non-significant.